![Reid Bissonnette](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Reid Bissonnette
Chief Tech/Sci/R&D Officer at
XENETIC BIOSCIENCES, INC.
Profile
Reid P.
Bissonnette currently works at Xenetic Biosciences, Inc., as Head-Translational Research & Development.
Dr. Bissonnette also formerly worked at Ligand Pharmaceuticals, Inc., as Associate Director, Huyabio International LLC, as Vice President-Pharmacology, Targazyme, Inc., as Vice President-Immuno-Oncology, and Arrivent BioPharma, Inc., as Head-Non-Clinical Research.
Dr. Bissonnette received his undergraduate degree and doctorate degree from McGill University.
Reid Bissonnette active positions
| Companies | Position | Start |
|---|---|---|
| XENETIC BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | - |
Former positions of Reid Bissonnette
| Companies | Position | End |
|---|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | - |
Targazyme, Inc.
 Targazyme, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals to improve clinical efficacy and safety in stem cell transplantation, immunotherapy for cancer, regenerative medicine and gene therapy | Corporate Officer/Principal | - |
Huyabio International LLC
 Huyabio International LLC Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Corporate Officer/Principal | - |
| ARRIVENT BIOPHARMA, INC. | Corporate Officer/Principal | - |
Training of Reid Bissonnette
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
3
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Ligand Pharmaceuticals, Inc.
 Ligand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and sells drug development technologies | Health Technology |
Huyabio International LLC
Huyabio International LLC Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Targazyme, Inc.
Targazyme, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals to improve clinical efficacy and safety in stem cell transplantation, immunotherapy for cancer, regenerative medicine and gene therapy | Health Technology |
Xenetic Biosciences, Inc.
 Xenetic Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biologic drugs, novel oncology therapeutics, and vaccinations | Health Technology |
Arrivent BioPharma, Inc.
 Arrivent BioPharma, Inc. Pharmaceuticals: OtherHealth Technology Engages in development and commercialization of cancer medicines | Health Technology |
- Stock Market
- Insiders
- Reid Bissonnette
